ATE255583T1 - Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen - Google Patents

Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Info

Publication number
ATE255583T1
ATE255583T1 AT99929792T AT99929792T ATE255583T1 AT E255583 T1 ATE255583 T1 AT E255583T1 AT 99929792 T AT99929792 T AT 99929792T AT 99929792 T AT99929792 T AT 99929792T AT E255583 T1 ATE255583 T1 AT E255583T1
Authority
AT
Austria
Prior art keywords
rays
shielding
metal complexes
chlorine derivatives
mono
Prior art date
Application number
AT99929792T
Other languages
English (en)
Inventor
Katsuo Aizawa
Shinjiro Sumi
Hirotada Takahashi
Noriaki Aman
Yoshihiko Terayama
Shuichi Gomi
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE255583T1 publication Critical patent/ATE255583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0085—Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A61K47/546—Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT99929792T 1998-07-10 1999-07-12 Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen ATE255583T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19571798 1998-07-10
PCT/JP1999/003752 WO2000002882A1 (en) 1998-07-10 1999-07-12 Novel x-ray intercepting metal complexes of chlorin derivatives

Publications (1)

Publication Number Publication Date
ATE255583T1 true ATE255583T1 (de) 2003-12-15

Family

ID=16345803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99929792T ATE255583T1 (de) 1998-07-10 1999-07-12 Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Country Status (9)

Country Link
US (1) US6413495B1 (de)
EP (1) EP1097935B1 (de)
JP (1) JP3692298B2 (de)
AT (1) ATE255583T1 (de)
AU (1) AU748625B2 (de)
CA (1) CA2336582C (de)
DE (1) DE69913351T2 (de)
ES (1) ES2212577T3 (de)
WO (1) WO2000002882A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386514T1 (de) * 1999-04-02 2008-03-15 Meiji Seika Kaisha Inhibition der vaskulären restenose nach einer angioplastie
EP1363548B1 (de) 2000-11-24 2015-08-12 Koninklijke Philips N.V. Vorrichtung zur diagnostizierung, bilderzeugung und medizinischen intervention
AU2002248360A1 (en) 2001-01-16 2002-08-19 Microdexterity Systems, Inc. Surgical manipulator
IL147898A (en) * 2002-01-30 2007-05-15 Yuval Golan A method of treating cancer based on the Ugar effect
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
JP4960602B2 (ja) * 2005-04-15 2012-06-27 三鷹光器株式会社 蛍光観察時の明視野光源及びそれを搭載した手術顕微鏡
RU2367434C1 (ru) * 2008-04-22 2009-09-20 Виктор Александрович Борисов Фотосенсибилизатор и способ его получения
RU2406726C1 (ru) * 2009-04-27 2010-12-20 Российская Федерация, от имени которой выступает государственный заказчик - Федеральное агентство по науке и инновациям ПРОИЗВОДНЫЕ 13(1)-N-{2-[N-(КЛОЗО-МОНОКАРБАДОДЕКАБОРАН-1-ИЛ)-МЕТИЛ]АМИНОЭТИЛ}АМИД-15(2),17(3)-ДИМЕТИЛОВОГО ЭФИРА ХЛОРИНА e6, ПРОЯВЛЯЮЩИЕ СВОЙСТВА ФОТОСЕНСИБИЛИЗАТОРА
ES2627420T3 (es) * 2009-06-12 2017-07-28 Erasmus University Medical Center Rotterdam Nanofotomedicamentos destinados al tratamiento fotodinámico del cáncer
RU2455039C1 (ru) * 2011-03-14 2012-07-10 Виктор Александрович Борисов Способ фотодинамической терапии злокачественных новообразований
US10766915B2 (en) 2013-03-15 2020-09-08 Sherri Ann McFARLAND Metal-based coordination complexes as photodynamic compounds and their use
US10149493B2 (en) 2015-04-29 2018-12-11 Corn Products Development, Inc. Flours that improve the crispness of battered potatoes
KR20180085717A (ko) 2015-09-24 2018-07-27 에이비비트로, 엘엘씨 친화성-올리고뉴클레오타이드 콘쥬게이트 및 그것의 사용
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
PL244960B1 (pl) 2021-02-15 2024-04-08 Dominika Szczepaniak Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8426102D0 (en) * 1984-10-16 1984-11-21 Ici Plc Thermal transfer printing
US4921973A (en) * 1984-12-10 1990-05-01 Johnson Matthey Inc. Platinum complexes and the like
US4815447A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP3253663B2 (ja) * 1992-01-20 2002-02-04 タマ生化学株式会社 放射線増感剤

Also Published As

Publication number Publication date
AU4651099A (en) 2000-02-01
EP1097935A4 (de) 2002-01-30
JP3692298B2 (ja) 2005-09-07
EP1097935B1 (de) 2003-12-03
WO2000002882A1 (en) 2000-01-20
ES2212577T3 (es) 2004-07-16
CA2336582A1 (en) 2000-01-20
DE69913351D1 (de) 2004-01-15
AU748625B2 (en) 2002-06-06
CA2336582C (en) 2006-06-06
EP1097935A1 (de) 2001-05-09
US6413495B1 (en) 2002-07-02
DE69913351T2 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
DE69913351D1 (de) Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
EP0461776A3 (en) X-ray analysis apparatus, especially computer tomography apparatus and x-ray target and collimator therefor
NO924820L (no) Anvendelse av 5,10,15,20 tetrakis(r-karboksyfenyl)porfin for aa paavise og behandle lungekreft
DE69919695D1 (de) Texaphyrin-konjugate und ihre anwendiung
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
FI972287L (fi) Uudenlaisia polysubstituoituja DTPA-johdoksia ja niiden metallikomplekseja, kyseisiä komplekseja sisältäviä farmaseuttisia aineita, niiden käyttö diagnosoinnissa ja terapiassa sekä menetelmiä kyseisten kompleksinmuodostajien ja kompleksien valmistamiseksi ja menetelmiä kyseisten.
ATE399560T1 (de) Pharmazeutische zusammensetzungen enthaltend arsentrioxid zur behandlung von nicht-hodgkihn- lymphome
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
EA200401622A1 (ru) Способы лечения ангиогенеза, роста опухолей и метастазов
BG42837A3 (bg) Метод за получаване на имуноглобулинови производни на винка алкалоиди
NZ237688A (en) Antibody-cytotoxic immunoconjugate-containing compositions and cancer treatment
Walker et al. Generation of polypeptide-templated gold nanoparticles using ionizing radiation
NO178571C (no) Analogifremgangsmåte for fremstilling av et bifunksjonelt chelateringsmiddel
AU2003238192A1 (en) New agents for magnetic imaging method
MX9200413A (es) Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando.
NO995109L (no) Formuleringer inneholdende 1,2,4-benzotriazinoksyder
RU97111568A (ru) Способ лечения онкологических больных
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
DK1154798T3 (da) Molekyler til behandling og diagnose af tumorer
Oren et al. Exposure to ultraviolet B radiation during phototherapy.
Peterson Prevention of oral complications in cancer patients
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents
Vicini Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties